Trials / Completed
CompletedNCT05618509
Immediate Effects of STENDO on the Walking Abilities of Patients with COPD (STENDO-COPD)
Immediate Effects of STENDO on the Walking Abilities of Patients with COPD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Elsan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The STENDO process is a heart rate synchronized massage system initially validated for the treatment of lymphedema. It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. This technique would also allow an improvement of endothelial function by a greater release of nitric oxide. Thus the capacity for physical exercise is potentially improved. The use of STENDO has never been evaluated in COPD (Chronic obstructive pulmonary disease) where physical capacity is impaired with, in particular, the presence of endothelial dysfunction. STENDO may improve walking performance. If these hypotheses are validated, the STENDO could be positioned as a complement to the exercise rehabilitation strategies offered to symptomatic COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | STENDO session | It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. The capacity for physical exercise is potentially improved. STENDO : 45 minutes, 2 legs and the pelvis, pression of 65mm Hg |
| OTHER | A six-minute walking distance test | Before and after STENDO session, the patient has to walk 6 minutes in a flat corridor (30m long) |
| OTHER | Near Infrared Spectroscopy | The goal is to measure the evolution of the oxygen consumption of the right leg during an effort on a bicycle at constant power for 5 minutes. |
| DEVICE | STENDO placebo | STENDO placebo : 45 minutes, on 2 legs and the pelvis, pression of 10 mmHg |
Timeline
- Start date
- 2023-01-04
- Primary completion
- 2024-05-27
- Completion
- 2024-05-27
- First posted
- 2022-11-16
- Last updated
- 2024-09-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05618509. Inclusion in this directory is not an endorsement.